Balaxi Pharma. Stock Price Analysis and Quick Research Report. Is Balaxi Pharma. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Balaxi Pharma.. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Balaxi Pharma. has a PE ratio of 38.7943897344076 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Balaxi Pharma. has ROA of 2.8078% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Balaxi Pharma. has a Current ratio of 1.2669.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Balaxi Pharma. has a ROE of 3.9462%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Balaxi Pharma. has a Debt to Equity ratio of 0.2514 which means that the company has low proportion of debt in its capital.

• Sales growth: Balaxi Pharma. has reported revenue growth of 32.5684% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Balaxi Pharma. for the current financial year is 1.23374944805946%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Balaxi Pharma. is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Balaxi Pharma. is Rs 0.6702. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Balaxi Pharma. in Ticker for free. Also, one can get the intrinsic value of Balaxi Pharma. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Balaxi Pharma. FAQs

Q1. What is Balaxi Pharma. share price today?
Ans: The current share price of Balaxi Pharma. is Rs 26.

Q2. What is the market capitalisation of Balaxi Pharma.?
Ans: Balaxi Pharma. has a market capitalisation of Rs 143.5395 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Balaxi Pharma.?
Ans: The PE ratio of Balaxi Pharma. is 38.7943897344076 and the P/B ratio of Balaxi Pharma. is 1.08951177301279, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Balaxi Pharma. share?
Ans: The 52-week high share price of Balaxi Pharma. is Rs 47.87, and the 52-week low share price of Balaxi Pharma. is Rs 15.2.

Q5. Does Balaxi Pharma. pay dividends?
Ans: Currently, Balaxi Pharma. does not pay dividends. Dividend yield of Balaxi Pharma. is around 0%.

Q6. What are the face value and book value of Balaxi Pharma. shares?
Ans: The face value of Balaxi Pharma. shares is Rs 2, while the book value per share of Balaxi Pharma. is around Rs 23.8639. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Balaxi Pharma.?
Ans: Balaxi Pharma. has a total debt of Rs 33.4365 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Balaxi Pharma.?
Ans: The ROE of Balaxi Pharma. is 3.9462% and ROCE of Balaxi Pharma. is 6.1371%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Balaxi Pharma. a good buy for the long term?
Ans: The Balaxi Pharma. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Balaxi Pharma. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Balaxi Pharma. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Balaxi Pharma.’s financials?
Ans: You can review Balaxi Pharma.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.